PROPANC BIOPHARMA INC (PPCB) stock analysis and AI prediction
The company facts of PROPANC BIOPHARMA INC, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About PROPANC BIOPHARMA INC
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $1.9 million
- Size
- Micro cap
- Employees
- 2
- Headquarters
- CAMBERWELL, VICTORIA, C3
- Listed since
- June 15, 2012
- Website
- propanc.com
More Healthcare stocks
Other micro cap stocks
Keep going
PPCB questions
What is the AI prediction for PPCB stock?
Each market day our model rates PROPANC BIOPHARMA INC (PPCB) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the PPCB prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for PPCB?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see PPCB options?
The PPCB options page opens its calls and puts, with price, volume, implied volatility and the Greeks.